Northwest Biotherapeutics: Q2 Earnings Snapshot

August 10, 2022 GMT

BETHESDA, Md. (AP) _ Northwest Biotherapeutics Inc. (NWBO) on Tuesday reported a loss of $29.7 million in its second quarter.

The Bethesda, Maryland-based company said it had a loss of 3 cents per share.

The cancer drug developer posted revenue of $477,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NWBO at https://www.zacks.com/ap/NWBO